AmerisourceBergen Corp. (NYSE:ABC) announced a quarterly dividend on Thursday, November 7th, RTT News reports. Investors of record on Monday, November 18th will be given a dividend of 0.40 per share on Monday, December 2nd. This represents a $1.60 annualized dividend and a yield of 1.89%.
AmerisourceBergen stock opened at $84.71 on Thursday. AmerisourceBergen has a fifty-two week low of $69.36 and a fifty-two week high of $94.75. The company has a debt-to-equity ratio of 1.40, a quick ratio of 0.56 and a current ratio of 0.95. The firm has a 50 day moving average price of $84.44 and a 200 day moving average price of $83.61. The company has a market capitalization of $18.39 billion, a PE ratio of 13.05, a price-to-earnings-growth ratio of 1.46 and a beta of 0.98.
Several research firms have commented on ABC. ValuEngine downgraded shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. TheStreet raised shares of AmerisourceBergen from a “c+” rating to a “b” rating in a research report on Thursday, August 1st. Morgan Stanley decreased their price objective on shares of AmerisourceBergen from $91.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, September 6th. Finally, Deutsche Bank began coverage on shares of AmerisourceBergen in a research report on Thursday, September 12th. They issued a “hold” rating and a $91.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $87.38.
In other news, CEO Steven H. Collis sold 19,905 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $86.08, for a total value of $1,713,422.40. Following the completion of the sale, the chief executive officer now directly owns 154,484 shares of the company’s stock, valued at $13,297,982.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP John G. Chou sold 13,997 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $86.29, for a total transaction of $1,207,801.13. Following the completion of the sale, the executive vice president now directly owns 65,782 shares of the company’s stock, valued at $5,676,328.78. The disclosure for this sale can be found here. Insiders sold 95,509 shares of company stock valued at $8,088,531 over the last ninety days. Corporate insiders own 27.80% of the company’s stock.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Further Reading: Understanding Market Liquidity
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.